Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Regorafenib Tablets

Approval Number

国药准字H20244635

Company湖南科伦制药有限公司

Registration Date

August 5, 2024

Drug Information

Generic Name

瑞戈非尼片

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

August 5, 2024

Company Information

Applicant Company

Company Name湖南科伦制药有限公司

Company Address

岳阳县城关镇荣新路（县生态工业园3号）

Manufacturing Company

Company Name湖南科伦制药有限公司

Company Address

湖南省岳阳经济技术开发区康王工业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

瑞戈非尼片 - NMPA 批准文号 | MedPath